Related Experiment Video
Updated: May 10, 2026

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
Published on: January 16, 2019
Novel locus for an inherited cardiomyopathy maps to chromosome 7
Lei Song1, Steven R DePalma, Maria Kharlap
1Howard Hughes Medical Institute, Department of Genetics, Harvard Medical School, Boston, MA, USA.
Insights
Researchers identified a new genetic locus on chromosome 7 linked to inherited heart conditions. This discovery suggests genetic causes of cardiac hypertrophy extend beyond sarcomere proteins, offering new insights into heart remodeling.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
Background:
- Genetic mutations are primary causes of hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy.
- Sarcomere protein mutations explain autosomal dominant HCM but not all cases.
- Other genetic factors can mimic HCM, and sarcomere gene mutations can cause dilated cardiomyopathy.
Purpose of the Study:
- To investigate novel genetic causes of inherited cardiomyopathies.
- To analyze a family with features of left ventricular hypertrophy, cardiac dilation, heart failure, and sudden death.
- To identify genetic underpinnings beyond known sarcomere gene mutations.
Main Methods:
- Genome-wide linkage analysis in a 4-generation kindred (32 individuals).
- Direct DNA sequencing of known HCM and dilated cardiomyopathy sarcomere genes.
- Histopathological examination of affected family members.
Main Results:
- No mutations were found in known sarcomere genes.
- Histopathology did not show typical signs of sarcomere mutation HCM (myocyte disarray, fibrosis).
- Linkage was established to a novel locus on chromosome 7 (7p12.1-7q21), with a maximum LOD score of 4.11.
Conclusions:
- A novel genetic locus on chromosome 7 is associated with inherited cardiac hypertrophy.
- This finding supports that molecular pathways for cardiac hypertrophy involve more than just sarcomere proteins.
- Further research to identify the causal gene mutation will elucidate cardiac remodeling mechanisms.
Background:
Genetic mutations are the most common cause of hypertrophic cardiomyopathy (HCM) and an increasingly recognized cause of dilated cardiomyopathy. Autosomal dominant HCM is caused by mutations in sarcomere proteins; such mutations are not universally present, however, and fail to account for &40% of cases of phenotypic HCM. To add further complexity, other genetic origins can mimic the gross clinical phenotype of HCM, and mutations in sarcomere genes have been demonstrated to cause dilated cardiomyopathy.
Methods And Results:
To explore novel genetic causes of inherited cardiomyopathies, genome-wide linkage analysis was used to study one kindred (4 generations, 32 individuals) with predominant clinical features of left ventricular hypertrophy in addition to cardiac dilation, end-stage heart failure, and sudden death. Of note, histopathology from 2 family members did not demonstrate myocyte disarray and fibrosis, indicating that this phenotype is not typical sarcomere mutation HCM. Direct DNA sequencing was performed on sarcomere genes known to cause HCM and dilated cardiomyopathy, and no mutations were identified. Linkage was then established to a novel locus on chromosome 7 (7p12.1-7q21). A maximum 2-point logarithm of odds score of 4.11 was obtained. Recombination events refine the disease interval between D7S506 and D7S3314, corresponding to a distance of 27.2 megabases.
Conclusions:
The discovery of a novel genetic locus in this family provides more evidence that molecular pathways leading to inherited cardiac hypertrophy extend beyond the sarcomere. Identification of the causal gene mutation and additional genotype-phenotype correlation studies will provide fundamental insight into mechanisms of cardiac remodeling.
More Related Videos
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
09:36Dual-Dye Optical Mapping of Hearts from RyR2R2474S Knock-In Mice of Catecholaminergic Polymorphic Ventricular Tachycardia
Published on: December 22, 2023
Related Concept Videos
Sex-linked Disorders
Pharmacogenomics: Identification of New Drug Targets
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy